Psykey, Inc.
OTC: CEOS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael Maher
- Employees
- 6
- Headquarters
- Toronto, Canada
- IPO year
- 2006
- Market cap
- $71.8K
- Website
- https://www.psykeyworld.com
Loading CEOS…
Loading profile data…Frequently asked questions about CEOS
What does Psykey, Inc. (CEOS) do?
Psykey, Inc. is dedicated to the exploration, formulation, and market introduction of specialized ingredients and compounds, including entheogenic, adaptogenic, and nootropic substances. These are incorporated into its functional product lines, which aim to enhance and optimize overall well-being. Furthermore, the company develops cutting-edge t...
Where does CEOS trade?
Psykey, Inc. (CEOS) trades on the Other OTC.
What sector is CEOS in?
Psykey, Inc. (CEOS) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Psykey, Inc.?
Michael Maher is the chief executive officer of Psykey, Inc. (CEOS).
Where is Psykey, Inc. headquartered?
Psykey, Inc. is headquartered in Canada.
Does CEOS pay a dividend?
Psykey, Inc. (CEOS) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CEOS go public?
Psykey, Inc. (CEOS) completed its initial public offering in 2006.